You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

May 6, 2015

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

Hydrocodone prescribed most to Medicare beneficiaries

Generic Vicodin (hydrocodone acetaminophen) was the most widely-prescribed drug to Medicare Part D beneficiaries in 2013, according to new data released by the Centers for Medicare & Medicaid Services last week. » Top prescribed drugs

PCORI approves trial to determine best aspirin dose to help heart disease patients

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors approved a 3-year, $14 million clinical trial designed to determine the best dose of aspirin to use to prevent heart attacks and strokes in people with heart disease. » Study details

Continuing Education

MTM essentials for asthma: Part 1

This month Drug Topics and the University of Connecticut School of Pharmacy offer a new CPE series: MTM for the patient with respiratory disease. Pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities (released April – December 2015). This month the series kicks off with MTM essentials for asthma management, covering the pathophysiology of asthma, clinical presentations of asthma, assessment methods, and nonpharmacologic management options.

To read and print the article with TEST questions, click here

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 15DT29-YKX36.


Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

FDA approves cough, cold drug

FDA has approved codeine polistirex and chlorpheniramine polistirex (Tuzistra XR, Vernalis plc and Tris Pharma) extended-release oral suspension, CIII (DEA Schedule III) for treating cough and cold. » Read more

 

RELATED ARTICLES

Medicare Part D scripts reach $103 billion

PCORI to give $138M to disease researchers

RESOURCES

Latest Clinical News

Powered by Modern Medicine Advanstar Medical Communications Group